The Role of WB-MRI in the Evaluation of Prostate Cancer Patients Treated With Lutetium - Prostate Specific Membrane Antigen (Lu-PSMA)

Name: The Role of WB-MRI in the Evaluation of Prostate Cancer Patients Treated With Lutetium - Prostate Specific Membrane Antigen (Lu-PSMA)
Published: 2021
License: Public Domain

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

metastatic castration resistant prostate cancer (mcrpc), wb-mri (whole body- magnetic resonance imaging), 177lu-psma 617, radio metabolic therapy (rmt), observational

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

The Role of WB-MRI in the Evaluation of Prostate Cancer Patients Treated With Lutetium - Prostate Specific Membrane Antigen (Lu-PSMA)

Related documents